Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00712634 · ClinicalTrials.gov registry record · Phase 1
Cytomegalovirus Vaccine in Healthy Participants
A Phase 1 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 46
- Enrollment target
NCT00712634 is a Phase 1 study that has completed, run by City of Hope Medical Center. The registered enrollment target is 46 participants.
The verdict
NCT00712634, a Phase 1 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 46 participants
- Enrollment target
Study Summary
RATIONALE: Vaccines may help the body build an effective immune response against cytomegalovirus. PURPOSE: This randomized phase I trial is studying the side effects and best dose of cytomegalovirus vaccine in healthy participants.
Interventions
- BIOLOGICAL CMVpp65-A*0201 peptide vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 1997-11 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00712634
The ClinicalTrials.gov registry entry for NCT00712634 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CMVpp65-A*0201 peptide vaccine is the first listed.
NCT00712634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00712634 about?
NCT00712634 is a clinical study titled "Cytomegalovirus Vaccine in Healthy Participants". RATIONALE: Vaccines may help the body build an effective immune response against cytomegalovirus. PURPOSE: This randomized phase I trial is studying the side effects and best dose of cytomegalovirus vaccine in healthy participants.
What is the current status of trial NCT00712634?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 1997-11. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00712634?
The interventions under investigation include: CMVpp65-A*0201 peptide vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00712634?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.